Stock Analiz

Anaptysbio, Inc. (ANAB) stock forecast and price target

Price $46.25 · data as of November 13, 2026

12-month price target

Average target$87.25
Upside / downside+88.6%
Analysts8
ConsensusStrong buy
Low $60.00Average $87.25High $140.00

Gold marker: average target · white marker: today’s price ($46.25)

Analyst ratings

Strong buy 3Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$3.24+804.8%$137M
Next fiscal year
ends December 31, 2027
$4.63+42.7%$165M
Next quarter
ends December 31, 2026
$1.05−33.2%$53M
Quarter after
ends March 31, 2027
$1.11—$41M

Consensus of the analysts covering Anaptysbio, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 88.6% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Anaptysbio’s intrinsic value about 43% below today’s market value, and it scores 2.6 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Anaptysbio stock price target?

The average 12-month target from 8 analysts is $87.25, 88.6% above the current price of $46.25 Targets range from $60.00 to $140.00.

Is Anaptysbio a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Anaptysbio expected to earn?

Analysts expect EPS of $3.24 for the fiscal year ending December 31, 2026 and $4.63 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.